Constance Gore
Acute Care · Morristown, NJNPI 1235192139
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,082 of the $3,657 with a category attached, or 84.3%. It is spread thinly across 14 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,068 and has fallen 77.2% since, to $243 in 2025. Among acute care clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 38 payments — averaging $96.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myriad Genetic Laboratories, Inc.$779
- AstraZeneca$680
- Seagen Inc.$467
- Johnson & Johnson$444
- Daiichi Sankyo Inc.$398
- E.r. Squibb & Sons, L.L.C.$208
- plus $681 from 8 others
Across 8 payments — averaging $215.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$2K
What the payments were for
- Speaking & faculty fees$37510%
- Food & beverage$3,08284%
- Education$2005%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 9 | $779 |
| AstraZeneca | 6 | $680 |
| Seagen Inc. | 5 | $467 |
| Johnson & Johnson | 4 | $444 |
| Daiichi Sankyo Inc. | 3 | $398 |
| E.r. Squibb & Sons, L.L.C. | 2 | $208 |
| GSK | 1 | $122 |
| Averitas Pharma Inc. | 1 | $120 |
| CTI Biopharma Corp. | 1 | $117 |
| Astellas Pharma US Inc | 1 | $100 |
| AbbVie | 1 | $96 |
| Exelixis Inc. | 1 | $70 |
| Eisai Inc. | 2 | $35 |
| Neurocrine Biosciences, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,657 in reported general payments places this provider in the 90th percentile of 656 acute care providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $6,414 |
| Anastrozole | 17 | $415 |
| Acyclovir | 11 | $308 |
| Tamoxifen Citrate | 11 | $154 |
Paid to pharmacies, not to this prescriber.
Other acute care in Morristown
- Linda SuplickiMorristown$12K
- Cristina ValdezMorristown$12K
- Jacqueline Fearon ClarkeMorristown$11K
- Karen EnglishMorristown$10K
- Ragitha SubodhMorristown$6K
- Kristen WhiteMorristown$4K
- Gina RizzoMorristown$4K
- Gabriella MagarelliHackensack$44K
- Per RosenkvistLivingston$29K
- Matthew OstroffPaterson$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.